Search results for "Cholinesterase Inhibitor"

showing 10 items of 57 documents

Acute toxicity of dichlorvos to Aphanius iberus (Cuvier & Valenciennes, 1846) and its anti-cholinesterase effects on this species

2008

This study evaluates the toxic effects of the organophosphate pesticide (OP) dichlorvos to the endangered Iberian toothcarp (Aphanius iberus). To this end, the lethal toxicity of dichlorvos based on 96 h-LC50 bioassays was determined in saline water (50 g/L), and in vivo effects of dichlorvos on cholinesterase (ChE) activity were investigated in adult female and male specimens. The 96 h-LC50 value determined by probit analysis was 3.17 mg/L (95% confidence limits: 1.34-3.97). The characterisation of the ChE using different substrates and specific inhibitors was also carried out in head and muscle tissues. Acetylthiocholine was the substrate preferred by both head and muscle ChE in males and…

Malemedicine.medical_specialtyAchéHealth Toxicology and MutagenesisAquatic ScienceToxicologychemistry.chemical_compoundInternal medicineDichlorvosmedicineAnimalsCholinesterasesCholinesterase (ChE)Cholinesterasebiologyintegumentary systemToxicityKillifishesMusclesOrganophosphateAcetylcholinesteraseSurvival AnalysisAcute toxicitylanguage.human_languageEnzyme assayEndocrinologyFishchemistryAphaniusToxicityDichlorvosbiology.proteinlanguageFemaleCholinesterase InhibitorsWater Pollutants ChemicalBiomarkers
researchProduct

Suppression by cholinesterase inhibition of a Ca(2+)-independent efflux of [3H]acetylcholine from the neuromuscular junction of the isolated rat diap…

1992

Abstract Endplate preparations of the left rat hemidiaphragm were incubated with [ 3 H]choline to label neuronal acetylcholine stores. Elevation of the concentration (13.5–135 mmol/l) of extracellular potassium chloride (KC1) stimulated the release of [ 3 H]acetylcholine in a concentration-dependent manner. KC1 (27 mmol/l) still caused a significant efflux of [ 3 H]acetylcholine in a Ca 2+ -free medium. Inhibitors of cholinesterase (physostigmine, diisopropylfluorophosphate) suppressed by 80% this Ca 2+ -independent efflux of [ 3 H]acetylcholine. Vesamicol (10 μmol/l), the blocker of the vesicular acetylcholine carrier, also suppressed the stimulated, Ca 2+ -independent efflux of [ 3 H]acet…

Malemedicine.medical_specialtyPhysostigmineVesamicolPhysostigmineDiaphragmNeuromuscular JunctionIn Vitro TechniquesTritiumNeuromuscular junctionCholinePotassium ChlorideRats Sprague-Dawleychemistry.chemical_compoundPiperidinesInternal medicinemedicineCholineAnimalsCholinesterasePharmacologyMuscarinebiologyAcetylcholineRatsEndocrinologymedicine.anatomical_structurechemistrybiology.proteinCalciumFemaleCholinesterase Inhibitorsmedicine.symptomAcetylcholinemedicine.drugMuscle contractionEuropean journal of pharmacology
researchProduct

Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: A systematic review and meta-analysis

2016

We conducted a systematic review and meta-analysis investigating the influence of acetylcholinesterase inhibitors (AChEIs) therapy on nutritional status and weight across observational and interventional studies. Two authors searched major electronic databases from inception until 10/14/2015 for longitudinal, open-label and randomised double-blind placebo controlled (randomised controlled trials (RCTs)) studies of AChEIs in patients with dementia reporting nutritional status outcome data. Out of 3551 initial hits, 25 studies (12 open-label trials, 9 RCTs and 4 longitudinal studies) including 10 792 patients with dementia were meta-analysed. In longitudinal studies (median follow-up 6 months…

Malemedicine.medical_specialtyPlaceboRisk Assessment03 medical and health sciences0302 clinical medicineArts and Humanities (miscellaneous)Weight lossAlzheimer DiseaseInternal medicineWeight LossmedicineDementiaHumansCumulative incidence030212 general & internal medicineAgedRandomized Controlled Trials as TopicGeriatricsbusiness.industryDEMENTIAmedicine.diseaseMETA-ANALYSISALZHEIMER'S DISEASE; DEMENTIA; GERIATRICS; META-ANALYSIS; Neurology (clinical); Psychiatry and Mental Health; Surgery; Arts and Humanities (miscellaneous)Acetylcholinesterase inhibitorsALZHEIMER'S DISEASEPsychiatry and Mental HealthMeta-analysisPhysical therapyObservational studyFemaleSurgeryCholinesterase InhibitorsNeurology (clinical)medicine.symptombusinessOlder peopleGERIATRICS030217 neurology & neurosurgery
researchProduct

Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome

2022

[Objective] To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs used for their treatment.

Maleprogressive multifocal leukoencepdiarrheacholinergic receptorplasma exchangemiddle agedadultimmunologic factornauseaanemiahypertrichosisageddrug withdrawaldiabetes mellitusdisease severityTRIALsafetycorticosteroidhypertensionImmunologyMiastenia gravismethotrexateArticlebulbar paralysispancytopeniaMuscular DiseasescompulsionMyasthenia Gravischolinesterase inhibitorcross-sectional studyHumansImmunologic FactorshumanRITUXIMABarthralgiaNeurologíaMalalties muscularsAgedRetrospective Studiesmyasthenia gravisleukopeniaabdominal painDrug testingmajor clinical studyCross-Sectional StudiesDrug side effectscyclophosphamideobservational studyNeurology (clinical)immunoglobulinFEATURESefficacyclinical outcomeelectrophysiological procedurescomputer assisted tomographyDOUBLE-BLINDTratamiento médicorituximabOutcome Assessment Health CareImmunologiamuscle specific tyrosine kinaseRegistriestacrolimusazathioprineMedicamentoGeneral Neurosciencenephrotoxicitygeneral condition deteriorationhyperplasiatrialMiddle Agedliver toxicitydrug toxicityunclassified drugfemaleEfectes secundaris dels medicamentsSAFETYFemaledouble-blindheadacheblindnessAdultAssaigs clínics de medicamentsmalefeaturesfollow uppneumoniacyclosporinemycophenolate mofetilprotein tyrosine kinaseimmunosuppressive agentallergyalopeciaEFFICACYclinical featureosteopeniaSpainprednisonehyperglycemiaautoantibodyFollow-Up Studies
researchProduct

Long-Term Response to Cholinesterase Inhibitor Treatment Is Related to Functional MRI Response in Alzheimer's Disease.

2015

<b><i>Background:</i></b> Treatment of Alzheimer's disease (AD) with cholinesterase inhibitors (ChEI) enhances cholinergic activity and alleviates clinical symptoms. However, there is variation in the clinical response as well as system level changes revealed by functional MRI (fMRI) studies. <b><i>Methods:</i></b> We investigated 18 newly diagnosed mild AD patients with fMRI using a face recognition task after a single oral dose of rivastigmine, a single dose of placebo and 1-month treatment with rivastigmine. The clinical follow-up took place at 6 and 12 months. <b><i>Results:</i></b> MMSE score difference between bas…

Malevsual processingCognitive NeuroscienceRivastigmineDiseasePharmacologyNeuropsychological TestsAlzheimerin tautimmoryta3112behavioral disciplines and activitiesBrain mappingAlzheimer DiseasemedicineHumansCholinesteraseAgedRivastigmineAged 80 and overmuistisairaudetBrain Mappingmedicine.diagnostic_testbiologyBrainMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance Imagingta3124Psychiatry and Mental healthLong term responsecolinesterase inhibitorbiology.proteinCholinergicFemaleCholinesterase InhibitorsGeriatrics and GerontologyAlzheimer's diseasePsychologyAlzheimer’s diseaseNeurosciencepsychological phenomena and processesmgnetic resonance imagingmedicine.drugDementia and geriatric cognitive disorders
researchProduct

KA-672 inhibits rat brain acetylcholinesterase in vitro but not in vivo.

1999

Abstract KA-672, a lipophilic benzopyranone derivative which is currently under development as a cognitive enhancer and antidementia drug, has previously been shown to have facilitatory effects on learning and memory in rats at doses of 0.1–1 mg/kg. We now report that KA-672 inhibited the activity of acetylcholinesterase (AChE), measured in vitro in rat brain cortical homogenate, with an IC 50 value of 0.36 μ M indicating that KA-672 may improve cognitive functions as a consequence of AChE inhibition. However, when we employed the microdialysis procedure to monitor acetylcholine (ACh) release from rat hippocampus, no effect of KA-672 (0.1–10 mg/kg) was found, indicating a lack of inhibition…

MicrodialysisMicrodialysisPharmacologyHippocampal formationBiologyHippocampusPiperazineschemistry.chemical_compoundCerebrospinal fluidIn vivoExtracellular fluidmedicineAnimalsBenzopyransCerebral CortexGeneral NeuroscienceBrainAcetylcholinesteraseAcetylcholineRatsKineticsBiochemistrychemistryEnzyme inhibitorbiology.proteinAcetylcholinesteraseCholinesterase InhibitorsAcetylcholinemedicine.drugNeuroscience letters
researchProduct

Evaluation of Galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: Part I

2008

Over the last decade, interest in delivering drugs through buccal mucosa has increased. As a major limitation in buccal drug delivery could be the low permeability of the epithelium, the aim of this study was to evaluate the aptitude of galantamine, useful in Alzheimer's disease, to penetrate the buccal mucosa. The evaluation of the ability of galantamine to permeate through the buccal epithelium was investigated using two permeation models. Firstly, in vitro permeation experiments were carried out using reconstituted human oral non-keratinised epithelium and Transwell diffusion cells system. Results were validated by ex vivo experiments using porcine buccal mucosa as membrane and Franz typ…

Pathologymedicine.medical_specialtySwinePharmaceutical ScienceAbsorption (skin)BiologyPermeabilityDiffusionstomatognathic systemPharmacokineticsSettore MED/28 - Malattie OdontostomatologichemedicineAnimalsHumansTransbuccal permeationCells CulturedGalantamineMouth MucosaAdministration BuccalEpithelial CellsGeneral MedicineBuccal administrationPermeationIn vitroEpitheliumstomatognathic diseasesKineticsmedicine.anatomical_structureSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryReconstituted human oral epithelium (HOE)Diffusion Chambers CultureCholinesterase InhibitorsPorcine buccal mucosaAlzheimer’s diseaseEx vivoBiotechnology
researchProduct

Quantitative structure-activity relationships for the toxicity of organophosphorus and carbamate pesticides to the Rainbow trout Onchorhyncus mykiss.

2006

This study has investigated the development of quantitative structure-activity relationships (QSARs) for the toxicity to rainbow trout Onchorhyncus mykiss Walbaum of 75 organophosphorus and carbamate pesticides. The toxicity data were obtained from an openly available toxicological database and were selected to be representative of a single endpoint. A large number of physicochemical and structural descriptors were calculated for the pesticides. QSAR models were developed using multiple linear regression and partial least-squares analyses. Following the removal of a small number of outliers, predictive QSARs were developed on small numbers of mechanistically relevant descriptors. Applying m…

Quantitative structure–activity relationshipCarbamatemedicine.medical_treatmentQuantitative Structure-Activity RelationshipRisk AssessmentToxicologyOrganophosphorus CompoundsmedicineAnimalsPesticidesToxicity dataChemistryQuantitative structureGeneral MedicinePesticideCarbamate pesticidesInsect ScienceEnvironmental chemistryOncorhynchus mykissToxicityMultivariate AnalysisLinear ModelsRainbow troutCarbamatesCholinesterase InhibitorsAgronomy and Crop SciencePest management science
researchProduct

Regulatory effects of polyamines on membrane-bound acetylcholinesterase

1974

The effects of putrescene, spermidine and spermine on membrane-bound acetylcholinesterase from human erythrocyte ‘ghosts’ and the solubilized enzyme of the electric organ of the electric eel were studied by kinetic methods. Measurements were made by using a photometric method which made it possible to record the enzyme reaction in the steady-state phase. Substrate-concentration-dependent activation and inhibition of acetylcholinesterase by polyamines is similar to that by Na+, K+, Ca2+, Mg2+ and certain quaternary and bisquaternary amines. The kinetics suggest an allosteric reaction mechanism. On the basis of the kinetic results a role for the polyamines as modulators of synaptic acetylchol…

Reaction mechanismErythrocytesSpermidineKineticsAllosteric regulationSpermineBiochemistrychemistry.chemical_compoundAllosteric RegulationPolyaminesPutrescineAnimalsHumansMolecular Biologychemistry.chemical_classificationElectric OrganbiologyCellular Interactions and Control ProcessesCell MembraneCell Biologybiology.organism_classificationAcetylcholinesteraseElectric eelEnzyme ActivationSpermidineKineticsEnzymechemistryBiochemistryElectrophorusAcetylcholinesteraseSpermineCholinesterase InhibitorsBiochemical Journal
researchProduct

Expression and possible functions of the cholinergic system in a murine embryonic stem cell line.

2007

The expression of a cholinergic system during embryonic development is a widespread phenomenon. However, no precise function could be assigned to it during early pre-neural stages and there are only few studies that document when it precisely starts to be expressed. Here, we examined the expression of cholinergic components in a murine embryonic stem cell line by RT-PCR, histochemistry, and enzyme activity measurements; the acetylcholine (ACh) content was measured by HPLC. We have demonstrated that embryonic stem cells express ACh, acetylcholine receptors, choline acetyltransferase (ChAT), acetyl- and butyryl-cholinesterase (AChE and BChE). Butyryl-cholinesterase (BChE) expression was highe…

Time FactorsBiologyGeneral Biochemistry Genetics and Molecular BiologyCell LineCholine O-AcetyltransferaseMicemedicineAnimalsCholinesterasesReceptors CholinergicGeneral Pharmacology Toxicology and PharmaceuticsEmbryonic Stem CellsAcetylcholine receptorCell ProliferationTetraisopropylpyrophosphamideReverse Transcriptase Polymerase Chain ReactionGene Expression ProfilingGeneral MedicineBenzenaminium 44'-(3-oxo-15-pentanediyl)bis(NN-dimethyl-N-2-propenyl-) DibromideCholine acetyltransferaseEmbryonic stem cellMolecular biologyAcetylcholineCell cultureButyrylcholinesteraseAcetylcholinesteraseCholinergicCholinesterase InhibitorsStem cellAcetylcholineAdult stem cellmedicine.drugLife sciences
researchProduct